Prevalence of complications associated with polymer-based alloplastic materials in nasal dorsal augmentation: a systematic review and meta-analysis
10.1186/s40902-022-00344-8
- Author:
Seied Omid KEYHAN
1
;
Shaqayeq RAMEZANZADE
;
Reza Golvardi YAZDI
;
Mohammad Amin VALIPOUR
;
Hamid Reza FALLAHI
;
Madjid SHAKIBA
;
Mahsa AEINEHVAND
Author Information
1. Maxillofacial Surgery & Implantology & Biomaterial Research Foundation, Tehran, Iran
- Publication Type:Review
- From:Maxillofacial Plastic and Reconstructive Surgery
2022;44(1):17-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Various techniques with different grafts and implants have been proposed to establish a smooth and symmetric nasal dorsum with adequate function. Broadly, two categories of materials have been used in this regard: alloplastic implant materials and autograft materials. The aim of these meta-analyses is to explore the incidence of complications after dorsum augmentation surgery using alloplastic materials.
Materials and methods:After duplication removal 491 papers remained that title and abstract were assessed for eligibility. Regarding the study type, 27 observational studies were included, 21 retrospective and 6 prospective case series. A total of 3803 cases were enrolled in this systematic review and meta-analysis.ResultTwenty-seven articles reported on complications and outcomes of dorsal augmentation rhinoplasty with synthetic materials. In a random-effects model, the weighted mean percentage was 2.75% (95% CI 1.61 to 4.17%). the weighted mean percentage were 1.91% (95% CI 0.77 to 3.54%), 0.72% (95% CI 0.316 to 1.31%), and 0.78% (95% CI 0.43 to 1.24%) respectively.
Conclusion:The widely used alloplasts were expanded polytetrafluoroethylene (ePTFE), high-density polyethylene, and silicone. The total rates for complications, infection, deviation, irregularity, hematoma, extrusion, and overcorrection were 2.75%, 1.91%, 0.72%, 0.70%, 0.78%, and 0.49%, respectively. The revision rate, based on the random effects model, was 6.40% with 95%CI (3.84 to 9.57).
